Recent Posts
- New Analysis of Phase 3 study presented at SUO 2020
- FerGene announces Landmark Phase 3 study published in The Lancet Oncology
- FerGene Provides Update on BLA for Nadofaragene Firadenovec
- FerGene to present bladder cancer data at 2020 ASCO Genitourinary Cancers Symposium
- FerGene Appoints David Meek Chief Executive Office
Recent Comments